Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells

Sponziello, Marialuisa; Rosignolo, Francesca; Celano, Marilena; Maggisano, Valentina; Pecce, Valeria; Rose, Roberta Francesca De; Lombardo, Giovanni Enrico; Durante, Cosimo; Filetti, Sébastiano; Damante, Giuseppe; Russo, Diego; Bulotta, Stefania

doi:10.1016/j.mce.2016.05.007

Cited by 124 publications

(107 citation statements)

References 55 publications

Supporting

Mentioning

103

Contrasting

Unclassified

Order By: Relevance

“…There are functional genes modulating EMT, resulting in tumor progression 32. Fibronectin 1 is one of the EMT regulators that was found to be upregulated in aggressive TC 11. In our study, the role of fibronectin 1 was investigated in PTC cell lines.…”

Section: Discussionmentioning

confidence: 92%

“…Serum fibronectin could be a promising biomarker for detecting breast cancer at an early stage 10. Another recent study indicated that fibronectin 1 was upregulated in aggressive TC 11. However, the biological function of fibronectin 1 in PTC has never been reported, and the clinical significance of fibronectin 1 in LNM of papillary TC is still unclear 12,13…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis

Xia¹,

Postma²,

Yang³

et al. 2017

OTT

View full text Add to dashboard Cite

Lymph node metastasis (LNM) is common in papillary thyroid cancer (PTC), and is an indicator of recurrence. The detailed molecular mechanism of LNM in PTC has not been well described. This study aimed to investigate the role of fibronectin 1 in PTC LNM and its clinical relevance. The expression of fibronectin 1 was confirmed in PTC tissues and cell lines. A correlation analysis was conducted and a receiver-operating characteristic curve obtained. The effect of fibronectin 1 on the proliferation of PTC cell lines was performed using a colony-formation assay and Cell Counting Kit 8. Cell-cycle analysis was performed with a flow-cytometry assay. Migration and invasion ability were evaluated by transwell and wound-healing assays. Fibronectin 1 was overexpressed in metastasized PTC. Overexpressed fibronectin 1 was positively correlated with PTC LNM. Receiver-operating characteristic analysis showed that the diagnostic accuracy of fibronectin 1 was 81.1%, with sensitivity of 80% and specificity of 82%. Overexpression of fibronectin 1 promoted proliferation, migration, and invasion in PTC. Fibronectin 1 plays a critical role in PTC metastasis by modulating the proliferation, migration, and invasion ability of PTC cells, and it is a valuable diagnostic biomarker for predicting PTC LNM.

show abstract

Section: Discussionmentioning

confidence: 92%

Section: Introductionmentioning

confidence: 99%

Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis

Xia¹,

Postma²,

Yang³

et al. 2017

OTT

View full text Add to dashboard Cite

show abstract

“…The EMT is important for tumor cells to acquire migratory and invasive properties [28, 29], and was recently implicated in several types of invasive human malignancies [30–33], including CRC [34]. Hence, EMT and its markers, including CDH1, are useful diagnostic biomarkers or therapeutic targets in CRC.…”

Section: Discussionmentioning

confidence: 99%

HINT2 downregulation promotes colorectal carcinoma migration and metastasis

Cai

Wang

et al. 2017

Oncotarget

View full text Add to dashboard Cite

Histidine triad nucleotide-binding 2 (HINT2), a member of the histidine triad proteins family, sensitizes cells to apoptosis in hepatocellular carcinoma. Here, we showed that HINT2 expression is lower in primary colorectal cancer (CRC) and metastasis tissues than in normal colorectal tissues, and that HINT2 abundance is inversely correlated with CRC tumor stage. Treating CRC cells with 5-aza-2′-deoxycytidine, a demethylating agent, upregulated HINT2, suggesting HINT2 downregulation is caused by methylation of the gene promoter. HINT2 downregulation increased tumor migration and invasion in vitro, promoted CRC cell metastasis in vivo, and increased expression of epithelial-to-mesenchymal transition (EMT) markers. Furthermore, HINT2 downregulation depended on hypoxia inducible factor (HIF)-2α-mediated transcriptional activation of zinc finger E-box-binding homeobox 1 (ZEB1). These results suggest that HINT2 downregulation promotes HIF-2α expression, which induces EMT and enhances CRC cell migration and invasion. HINT2 may thus a useful clinical indicator of CRC progression and metastasis risk.

show abstract

“…SERPINE1 may also contribute to tumor aggressiveness by promoting tumor angiogenesis 26,27. FN1 has long been considered as an epithelial–mesenchymal transition (EMT) marker and is associated with angiogenesis and metastasis 28,29. Genes with lower AUC may significantly complement the model, however, we are more inclined to select biomarkers which are up-regulated in recurrent tumors compared to non-recurrent tumors such as THBS1, SERPINEE1, and FN1.…”

Section: Discussionmentioning

confidence: 99%

Computational analysis of mRNA expression profiles identifies a novel triple-biomarker model as prognostic predictor of stage II and III colorectal adenocarcinoma patients

Cheng¹,

Hu²,

Chen³

et al. 2018

CMAR

View full text Add to dashboard Cite

IntroductionAlthough remarkable progress has been made to determine the prognosis of patients with colorectal cancer (CRC), it is inadequate to identify the subset of high-risk TNM stage II and stage III patients that have a high potential of developing tumor recurrence and may experience death. In this study, we aimed to develop biomarkers as a prognostic signature for the clinical outcome of CRC patients with stage II and stage III.Materials and methodsWe performed a systematic and comprehensive discovery step to identify recurrence-associated genes in CRC patients through publicly available GSE41258 (n=253) and GSE17536 (n=107) datasets. We subsequently determined the prognostic relevance of candidate genes in stage II and III patients and developed a triple-biomarker for predicting RFS in GSE17536, which was later validated in an independent cohort GSE33113 dataset (n=90).ResultsBased upon mRNA expression profiling studies, we identified 45 genes which differentially expressed in recurrent vs non-recurrent CRC patients. By using Cox proportional hazard models, we then developed a triple-marker model (THBS2, SERPINE1, and FN1) to predict prognosis in GSE17536, which successfully identified poor prognosis in stage II and stage III, particularly high-risk stage II CRC patients.DiscussionNotably, we found that our triple-marker model once again predicted recurrence in stage II patients in GSE33113. Kaplan–Meier survival analysis demonstrated that patients with high scores have a poor outcome compared to those with low scores. Our triple-marker model is a reliable predictive tool for determining prognosis in CRC patients with stage II and stage III, and might be able to identify high-risk patients that are candidates for more targeted personalized clinical management and surveillance.

show abstract

Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells

Cited by 124 publications

References 55 publications

Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis

Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis

HINT2 downregulation promotes colorectal carcinoma migration and metastasis

Computational analysis of mRNA expression profiles identifies a novel triple-biomarker model as prognostic predictor of stage II and III colorectal adenocarcinoma patients

Contact Info

Product

Resources

About